WARNING: Trend forecast is still in the development phase and should be used with caution. Bionano Genomics trades on the NASDAQ under the ticker symbol "BNGO.". 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last year. Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown Significance. ... Analyst Forecasts. Analyst projections state that BNGO is forecast to be at a low of $0.75 and a high of $2. BNGO stock has risen by more than 1,000 percent in over a month, which is a huge movement for a stock. Ribbon Communications (NASDAQ: RBBN) Stock Providing Pullback Opportunities, Plug Power Stock is Recharging for Another Run, 3 Dividend Stocks to Help You Sleep Well at Night, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, This Stock Went from Less Than $1 to Above $10 in a Few Weeks, How to Buy Bionano Genomics Inc. (BNGO) Stock, Analyst Pounds the Table on Bionano (BNGO) Stock, Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed, Analyzing Bionano Genomics's Unusual Options Activity. Bionano Genomics (NASDAQ:BNGO) Earnings Information Bionano Genomics last issued its quarterly earnings results on November 13th, 2020. Get the latest Bionano Genomics, Inc. BNGO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Currently, only two analysts cover the stock and both of them have a buy rating. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The BioNano Genomics Inc. stock price fell by -5.65% on the last day (Thursday, 4th Feb 2021) from $11.85 to $11.18. Please read the full disclaimer here. This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. Vote “Outperform” if you believe BNGO will outperform the S&P 500 over the long term. Investors can use this … NASDAQ:BNGO continued its 2021 momentum as the red-hot genomics sector keeps hitting new highs on a daily basis. Based on our forecasts, a long-term increase is expected, the "BNGO" stock price prognosis for 2026-02-13 is 42.652 USD. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. Currently, the average revenue forecast for … Bionano Genomics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. Is It Too Late to Buy Bionano Genomics Stock? Bionano Genomics has only been the subject of 1 research reports in the past 90 days. And, here we go again, as a supply crisis could fuel a new lithium craze. Wall Street analysts have given Bionano Genomics a "Buy" rating, but there may be better short-term opportunities in the market. Bionano Genomics has a market capitalization of $1.53 billion and generates $10.13 million in revenue each year. BNGO stock was purchased by a variety of institutional investors in the last quarter, including Pura Vida Investments LLC, Jane Street Group LLC, ExodusPoint Capital Management LP, Northern Trust Corp, Archford Capital Strategies LLC, Squarepoint Ops LLC, Creative Planning, and BlackRock Inc.. View insider buying and selling activity for Bionano Genomics or or view top insider-buying stocks. Want to see which stocks are moving? Did The Underlying Business Drive Bionano Genomics' (NASDAQ:BNGO) Lovely 997% Share Price Gain? By using the site you agree and are held The reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.02. Find the latest Bionano Genomics, Inc. (BNGO) stock quote, history, news and other vital information to help you with your stock trading and investing. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Their forecasts range from $1.00 to $14.00. BNGO stock was sold by a variety of institutional investors in the last quarter, including Triton Wealth Management PLLC, and Proequities Inc.. View insider buying and selling activity for Bionano Genomics or view top insider-selling stocks. 10 employees have rated Bionano Genomics CEO R. Erik Holmlin on Glassdoor.com. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Bionano Genomics has a P/B Ratio of 91.09. BNGO 11.06 0.84 (8.22%). BNGO's stock forecast. 4 Wall Street analysts that have issued a 1 year BNGO price target, the average BNGO price target is $10.94, with the highest BNGO stock price forecast at $15.00 and the lowest BNGO stock price forecast at $0.75. Get the latest Bionano Genomics, Inc. (BNGO) stock news and headlines to help you in your trading and investing decisions. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 MarketBeat's community ratings are surveys of what our community members think about Bionano Genomics and other stocks. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. You can opt out at any time. Bionano Genomics does not have a long track record of dividend growth. BNGO Stock Predictions. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Get daily stock ideas top-performing Wall Street analysts. View which stocks are hot on social media with MarketBeat's trending stocks report. 4 equities research analysts have issued twelve-month target prices for Bionano Genomics' shares. The company can be reached via phone at 858-888-7600 or via email at [email protected]. BNGO Stock Trend The stock lies in the middle of a very wide and falling trend in the short … Users should not base their investment decision upon "StockInvest.us". BNGO updated stock price target summary. This time it won’t be different! View Bionano Genomics' Short Interest. Their forecasts range from $1.00 to $15.00. (Add your “underperform” vote.). About the Bionano Genomics Inc stock forecast Unlock SECRET Features HERE for $1! Bionano Genomics has received 146 “outperform” votes. Start Your Risk-Free Trial Subscription Here, Stocks fall as yields continue to climb; GameStop surges, World shares skid, US futures turn higher after Wall St rout, Tech rout pulls Nasdaq down 3.5%, biggest loss since October, Game on, again: GameStop surges and no one truly knows why, Vaccination 'passports' may open society, but inequity looms, Closing prices for crude oil, gold and other commodities, House to vote on virus bill; arbiter says wage hike a no-go, Guardion Health Sciences Stock Needs to Give Investors More Than Survival, Wait For a Better Price Before Placing a Bet On Churchill Downs, 3 Small Cap Dividend Stocks with Growth Prospects. Get Our PREMIUM Forecast Now, from ONLY $7.49! View all of BNGO's competitors. Only 1.20% of the stock of Bionano Genomics is held by insiders. Learn more. Bionano Genomics' stock is owned by a number of retail and institutional investors. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Unprepared investors always get killed in megatrends. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Learn everything you need to know about successful options trading with this three-part video course. Only 5.64% of the stock of Bionano Genomics is held by institutions. Investors can use this forecasting interface to forecast Bionano Genomics historical stock prices and determine the direction of Bionano Genomics's future trends based on various well-known forecasting models. SmartAsset's free quiz matches you with fiduciary financial advisors in your area in 5 minutes. Dow Jones, a News Corp company. The price target was set to $1.50 → $15.00. View the latest Bionano Genomics Inc. (BNGO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Bionano Genomics had a negative trailing twelve-month return on equity of 749.14% and a negative net margin of 510.42%. The company earns $-29,820,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis. See what's happening in the market right now with MarketBeat's real-time news feed. Your losses are our losses too. 100% Free, Limited Time Only! © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Some companies that are related to Bionano Genomics include Coherent (COHR), Pacific Biosciences of California (PACB), Berkeley Lights (BLI), Quanterix (QTRX), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), EyePoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), Astrotech (ASTC), Precipio (PRPO), Scientific Industries (SCND), HTG Molecular Diagnostics (HTGM), Pressure BioSciences (PBIO), BioForce Nanosciences (BFNH) and Arrayit (ARYC). According to analysts' consensus price target of $7.81, Bionano Genomics has a forecasted downside of 22.0% from its current price of $10.02. View analyst ratings for Bionano Genomics or view top-rated stocks. On average, they anticipate Bionano Genomics' stock price to reach $4.44 in the next year. All rights reserved. (Add your “outperform” vote. Its Saphyr system includes an instrument, chip consumables, reagents, and a suite of data analysis tools. Receive a free world-class investing education from MarketBeat. To see all exchange delays and terms of use please see disclaimer. and has now fallen 3 days in a row. In order for the stock price to hit the forecast high, the stock would need to surge -76.28% from its current level, while the stock would need to crash -91.1% from its current level to reach the projected low. Is there any upside left for the stock? BNGO | Complete Bionano Genomics Inc. stock news by MarketWatch. BNGO stock price NASDAQ: BNGO is changing hands at around $5.66 at the time of writing, up some 20%. Top institutional investors include Pura Vida Investments LLC (1.37%), Jane Street Group LLC (0.24%), Northern Trust Corp (0.19%), ExodusPoint Capital Management LP (0.11%), Archford Capital Strategies LLC (0.05%) and Squarepoint Ops LLC (0.04%). Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. featured in The Global Fintech Index 2020 as the top Fintech company of the country. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Based on aggregate information from My MarketBeat watchlists, some companies that other Bionano Genomics investors own include Matinas BioPharma (MTNB), Gran Tierra Energy (GTE), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Cannabics Pharmaceuticals (CNBX), KushCo (KSHB), Aeterna Zentaris (AEZS) and OrganiGram (OGI). BNGO Stock Analysis Overview What this means: Bionano Genomics Inc (BNGO) gets an Overall Rank of 60, which is an above average rank under InvestorsObserver's stock ranking system. The official website for Bionano Genomics is www.bionanogenomics.com. Should Fiverr Investors Be Worried About LinkedIn? This upgrade primarily reflects an upward trend in … BNGO stock is up 280% this year as its story begins to unfold. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California. Get short term trading ideas from the MarketBeat Idea Engine. BioNano Genomics stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for BNGO in the last 3 months. Bionano Genomics' stock was trading at $0.5770 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Bionano Genomics Stock Forecast is based on your current time horizon. Roth Capital Partners and Maxim Group acted as the underwriters for the IPO and LifeSci Capital was co-manager. This suggests that the stock has a possible downside of 59.8%. View real-time stock prices and stock quotes for a full financial overview. Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know Zacks - Wed Feb 3, 4:45PM CST Zacks Equity Research - ZACKS - Wed Feb 3, 4:45PM CST Bionano Genomics, Inc. (BNGO) closed at $11.85 in the latest trading session, marking a -1.41% move from the prior day. Fundamental company data provided by Zacks Investment Research. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Learn about financial terms, types of investments, trading strategies and more. 87,971 This suggests that the stock has a possible downside of 22.0%. Get the latest BioNano Genomics (BNGO) stock price quote with real-time news, financials, charts and other important investing information. ... (BNGO) stock forecast and price target. © American Consumer News, LLC dba MarketBeat® 2010-2021. Each advisor is legally bound to act in your best interest. View institutional ownership trends for Bionano Genomics. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View which stocks have been most impacted by COVID-19. The price boost had a significant effect on investor sentiment, sending the stock 37% higher. View Bionano Genomics' earnings history. Real-time data provided for free by IEX. By the close of trading, the genome analysis company's stock price was up 28.4%. The company issued 2,500,000 shares at $6.00-$7.00 per share. All users should speak with their financial advisor before buying or selling any securities. Learn more. Firstly, the revenue outlook for 2021 looks positive according to analyst forecasts. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.02. View analysts' price targets for Bionano Genomics or view top-rated stocks among Wall Street analysts. Bionano Genomics has received a consensus rating of Buy. Activity in shares has been substantial for a company worth less than $1 billion. Find real-time BNGO - Bionano Genomics Inc stock quotes, company profile, news and forecasts from CNN Business. Financial outlook for BNGO stock in 2021 and beyond. With a 5-year investment, the revenue is expected to be around +212.59%. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Bionano Genomics, Inc. (NASDAQ:BNGO) posted its quarterly earnings results on Friday, November, 13th. Export data to Excel for your own analysis. On average, they anticipate Bionano Genomics' share price to reach $7.81 in the next twelve months. ), Bionano Genomics has received 150 “underperform” votes. During the day the stock fluctuated 5.36% from a day low at $11.01 to a day high of $11.60. Based on an average daily volume of 71,690,000 shares, the short-interest ratio is currently 0.4 days. Identify stocks that meet your criteria using seven unique stock screeners. Bionano Genomics, Inc. Common Stock (BNGO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. You may vote once every thirty days. BioNano Genomics, Inc NASDAQ Updated Feb 24, 2021 7:29 PM. Bionano Genomics Inc. analyst estimates, including BNGO earnings per share estimates and analyst recommendations. Your current $100 investment may be up to $312.59 in 2026. Please log in to your account or sign up in order to add this asset to your watchlist. >> As of 2021 February 21, Sunday current price of BNGO stock is 13.580$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). The firm earned $2.20 million during the quarter, compared to analyst estimates of $2.15 million. On February 08, 2021 "Oppenheimer" gave "" rating for BNGO. The P/E ratio of Bionano Genomics is -5.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Going from strength to strength – BioNano Genomics (NASDAQ: BNGO) has surged by 28.73% on Monday, closing at $12.58. We are all together in this COVID-19 pandemic. Bionano's stock forecast Being a penny stock , Bionano isn't well covered by analysts. Terms of Use and Privacy Policy. Compare Top Brokerages Here. While shares are off the fresh 52 Bionano Genomics' mailing address is 9540 TOWNE CENTRE DRIVE SUITE 100, SAN DIEGO CA, 92121. Bionano Genomics employs 97 workers across the globe. Should I buy or sell BNGO stock? Do Not Sell My Information. Best Stocks in the Past Week: Bionano Genomics Surges, Why Bionano Genomics Stock Is Trading Higher Today, view top-rated stocks among Wall Street analysts, Pennsylvania Real Estate Investment Trust (PEI), Receive Analysts' Upgrades and Downgrades Daily. Some cases might produce unexpected results such as negative prices at the end of the trend. Bionano Genomics does not currently pay a dividend. 4 weeks BNGO Stock Forecast: BioNano Genomics Inc soars by 28.37% after raising funds, bullish analysis FXStreet . Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. Shares of Bionano Genomics (NASDAQ:BNGO) furthered their recent gains on Monday. The stock may cool off, but it looks like there are many chapters to come for the firm. The consensus among Wall Street analysts is that investors should "buy" Bionano Genomics stock. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Given the current short-term trend, the stock is expected to rise 999.99% during the next 3 months and, with a 90% probability hold a price between $110.22 and $192.00 at the end of this 3-month period. Bionano Genomics, Inc. (BNGO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). In the past three months, Bionano Genomics insiders have not sold or bought any company stock. According to . View our earnings forecast for Bionano Genomics. View our full suite of financial calendars and market data tables, all for free. Bionano Genomics' management team includes the following people: 20 Questions To See If You Can Retire Comfortably. R. Erik Holmlin has an approval rating of 73% among Bionano Genomics' employees. The upside will depend on … Get the latest BioNano Genomics (BNGO) stock price quote with real-time news, financials, charts and other important investing information. The price has fallen in 6 of the last 10 days, but is still up by 35.19% over the past 2 weeks. View IEX’s Terms of Use. The business earned $2.20 million during the quarter, compared to the consensus estimate of $2.15 million. The latest BNGO stock news, ARKG updates and 2 major BNGO stock catalysts to watch. Looking for new stock ideas? Bionano Genomics has received 50.68% “underperform” votes from our community. Bionano (BNGO) to Report Q4 Earnings: What's in the Offing? Shares of BNGO can be purchased through any online brokerage account. Bionano Genomics saw a increase in short interest in the month of January. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. One share of BNGO stock can currently be purchased for approximately $10.02. Finding the right financial advisor to fit your needs doesn't have to be hard. Earnings for Bionano Genomics are expected to grow in the coming year, from ($0.43) to ($0.22) per share. (BNGO) raised $16 million in an IPO on the week of August 20th 2018. Vote “Underperform” if you believe BNGO will underperform the S&P 500 over the long term. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. 4 analysts have issued twelve-month price objectives for Bionano Genomics' stock. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas. Sign-up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Bionano Genomics Inc Stock Price Forecast, "BNGO" Predictons for2021 Bionano Genomics Inc (BNGO) Analyst Forecast Next 12 months MEAN $10.94 -20.17% HIGH $15.00 +9.49% LOW $0.75 -94.53% Current Price $13.70 52-week … As of January 15th, there was short interest totaling 25,470,000 shares, an increase of 63.1% from the December 31st total of 15,620,000 shares. MarketBeat just released five new trading ideas, but Bionano Genomics wasn't one of them. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings. Since then, BNGO stock has increased by 1,636.6% and is now trading at $10.02. liable for your own investment decisions and agree to Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. There are currently 1 hold rating and 3 buy ratings for the stock. BNGO -- USA Stock : USD 13.57 0.75 5.85% : Bionano Genomics Stock Forecast is based on your current time horizon. Bionano Genomics is headquartered at 9540 TOWNE CENTRE DRIVE SUITE 100, SAN DIEGO CA, 92121. View Bionano Genomics, Inc. BNGO investment & stock information.
Delta Cam Lock, Craigslist Houston For Sale Furniture, Gotham Garage 69 Mustang Mach 1, Breaking News Fort Atkinson, Wi, "a Theory Of Cognitive Dissonance" 1957 Pdf, Nike Dunk Low Oatmeal Stockx, Noah Van Gabranth Ff12, Brother Sq9285 Walking Foot,